Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Respiratory Syncytial Virus Infections 1Lymphoma, Follicular 1COVID-19 1Autoimmune Diseases 1

Interventions

Standard of Care 8Hydroxychloroquine 4BNT162 Vaccine 4Practice Guidelines as Topic 3Blood Specimen Collection 32019-nCoV Vaccine mRNA-1273 3tocilizumab 2sotrovimab 2cilgavimab and tixagevimab drug combination 2Specimen Handling 2Sodium Chloride 2CVnCoV COVID-19 vaccine 2COVID-19 Vaccines 2COH04S1 COVID-19 vaccine 2Azithromycin 2sinovac COVID-19 vaccine 1selinexor 1remdesivir 1proxalutamide 1palbociclib 1ogalvibart 1monalizumab 1lenzilumab 1crexavibart 1ciclesonide 1bemcentinib 1avdoralimab 1acalabrutinib 1XAV-19 1Therapeutics 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × COVID-19 × remdesivir × Clear all
NCT04575064 2024-10-09

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Klinikum Bremen-Mitte, gGmbH

Phase 2/3 Withdrawn
Lymphoid

COVID-19, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡